Clearside Biomedical, Inc.
CLSDDelisted Dec 8, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001539029
Clearside Biomedical, Inc. was delisted on Dec 8, 2025; its insiders filed their last Form 4 on Feb 24, 2025; 26 institutions reported holding it in 13F filings for Q3 2025, worth $2.18M in total; no superinvestor held it.
Q2 2023 vs. Q1 2023
How the institutions holding Clearside Biomedical, Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Of which not filed for Q2 2023 | Q2 2023 | Change |
|---|---|---|---|---|
| Holders | 51 | 1 | 54 | +4 |
| Shares | 8.75M | 14.0K | 8.59M | −138.5K (−1.6%) |
| Value | $9.09M | $14.6K | $9.62M | +$546.9K (+6.0%) |
1 institution that held it in Q1 2023 haven't filed for Q2 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (9)
Institutions that held Clearside Biomedical, Inc. at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| TownSquare Capital, LLC | 110,000 | $123.2K | 0.00% |
| Brown Wealth Management, LLC | 110,000 | $123.2K | 0.06% |
| Virtu Financial LLC | 33,844 | $38.0K | 0.00% |
| Millennium Management LLC | 33,298 | $37.3K | 0.00% |
| National Asset Management, Inc. | 31,000 | $34.7K | 0.00% |
| Jane Street Group, LLC | 15,946 | $17.9K | 0.00% |
| Two Sigma Securities, LLC | 15,719 | $17.6K | 0.00% |
| Simplex Trading, LLC | 2,170 | $2.00K | 0.00% |
| Rhumbline Advisers | 1,092 | $1.22K | 0.00% |
Sold out (5)
Institutions that held Clearside Biomedical, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Janney Montgomery Scott LLC | 100,000 | $104.0K |
| Lincoln National Corp | 92,300 | $96.0K |
| Baader Bank INC | 13,814 | $11.2K |
| Soltis Investment Advisors LLC | 10,000 | $10.4K |
| Tower Research Capital LLC (TRC) | 64 | $0 |
Not filed for Q2 2023 yet (1)
Institutions that held Clearside Biomedical, Inc. at the end of Q1 2023 and haven't filed a 13F for Q2 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Asset Management Corp | 14,000 | $14.6K |